Xeloda · DIN 02238454 · 500 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.Discontinued December 7, 2022 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Xeloda · DIN 02238454
Manufacturer: Hoffmann-La Roche Limited; listing date 2001-06-07
Health Canada: Cancelled post market since 2022-12-07 · brand XELODA · ATC L01BC06 CAPECITABINE · form Tablet · route Oral · ingredients CAPECITABINE 500 MG · company Cheplapharm arzneimittel gmbh · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02238454)
Source record
DIN 02238454: Xeloda
Raw flags: sec3=Y
Item: 100000137; group id 149; item number 0253; lccId None; manufacturer id HLR
Source form: Tab; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $6.4933; ministry $1.5250
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02238454
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=61874
Interchangeable products
Ach-Capecitabine · DIN 02426765 · $1.5250
Capecitabine · DIN 02514990 · $1.5250
Capecitabine · DIN 02519887 · $1.5250
Mint-Capecitabine · DIN 02508028 · $1.5250
Sandoz Capecitabine · DIN 02421925 · $1.5250
Taro-Capecitabine · DIN 02457504 · $1.5250
Teva-Capecitabine · DIN 02400030 · $1.5250
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since December 7, 2022 — choose a marketed DIN from the same-category list.